Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients

Clinical and Experimental Allergy

Volumn 45, Issue 2, 2015, Pages 423-437

  Becker, K L ^a   Gresnigt, M S ^a   Smeekens, S P ^a   Jacobs, C W ^a   Magis Escurra, C ^a   Jaeger, M ^a   Wang, X ^a   Lubbers, R ^a   Oosting, M ^a   Joosten, L A B ^a   Netea, M G ^a   Reijers, M H ^a   van de Veerdonk, F L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aspergillus fumigatus; Allergic bronchopulmonary aspergillosis; Interferon ; Interleukin 13; Interleukin 5

Indexed keywords

ADALIMUMAB; CD19 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; CYTOKINE; DECTIN 1; ETANERCEPT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; OX40 LIGAND; PATTERN RECOGNITION RECEPTOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; CD11B ANTIGEN; FUNGUS ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LECTIN; LIGAND;

ADULT; AGED; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENOTYPE; HUMAN; MALE; PATTERN RECOGNITION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TH2 CELL; YOUNG ADULT; ANTAGONISTS AND INHIBITORS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; CASE CONTROL STUDY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; MUTATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ADULT; AGED; ANTIBODIES, FUNGAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; LIGANDS; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; MUTATION; PHAGOCYTOSIS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 84923108179     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12354     Document Type: Article

References (66)

1. Knutsen AP, Bush RK, Demain JG et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012; 129:280-91; quiz 292-283.
2. Knutsen AP. Immunopathology and immunogenetics of allergic bronchopulmonary aspergillosis. J Allergy 2011; 2011:785983.
3. Gresnigt MS, Netea MG, van de Veerdonk FL. Pattern recognition receptors and their role in invasive aspergillosis. Ann N Y Acad Sci 2012; 1273:60-7.
4. Stuehler C, Khanna N, Bozza S et al. Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 2011; 117:5881-91.
5. Chai LY, van de Veerdonk F, Marijnissen RJ et al. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology 2010; 130:46-54.
6. Bouzani M, Ok M, McCormick A et al. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release. J Immunol 2011; 187:1369-76.
7. Pulendran B, Artis D. New paradigms in type 2 immunity. Science 2012; 337:431-5.
8. Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res 2010; 690:24-39.
9. Chishimba L, Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma 2012; 49:423-33.
10. Ramaprakash H, Ito T, Standiford TJ, Kunkel SL, Hogaboam CM. Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice. Infect Immun 2009; 77:108-19.
11. Buckland KF, O'Connor E, Murray LA, Hogaboam CM. Toll like receptor-2 modulates both innate and adaptive immune responses during chronic fungal asthma in mice. Inflamm Res 2008; 57:379-87.
12. Van Dyken SJ, Garcia D, Porter P et al. Fungal chitin from asthma-associated home environments induces eosinophilic lung infiltration. J Immunol 2011; 187:2261-7.
13. Ferwerda B, Ferwerda G, Plantinga TS et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009; 361:1760-7.
14. Netea MG, Warris A, Van der Meer JW et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 2003; 188:320-6.
15. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF et al. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 2007; 56:2957-67.
16. Gresnigt MS, Becker KL, Smeekens SP et al. Aspergillus fumigatus-induced IL-22 is not restricted to a specific Th cell subset and is dependent on complement receptor 3. J Immunol 2013; 190:5629-39.
17. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003; 197:1119-24.
18. Fagiolo U, Kricek F, Ruf C, Peserico A, Amadori A, Cancian M. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000; 106:567-72.
19. Mezger M, Einsele H, Loeffler J. Genetic susceptibility to infections with Aspergillus fumigatus. Crit Rev Microbiol 2010; 36:168-77.
20. Trynka G, Hunt KA, Bockett NA et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011; 43:1193-201.
21. Chai LY, Kullberg BJ, Vonk AG et al. Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun 2009; 77:2184-92.
22. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001; 413:36-7.
23. Lilly LM, Gessner MA, Dunaway CW et al. The beta-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. J Immunol 2012; 189:3653-60.
24. O'Brien XM, Heflin KE, Lavigne LM et al. Lectin site ligation of CR3 induces conformational changes and signaling. J Biol Chem 2012; 287:3337-48.
25. Le Cabec V, Carreno S, Moisand A, Bordier C, Maridonneau-Parini I. Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J Immunol 2002; 169:2003-9.
26. Kaur S, Gupta VK, Shah A, Thiel S, Sarma PU, Madan T. Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol 2006; 143:414-9.
27. Kreindler JL, Steele C, Nguyen N et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest 2010; 120:3242-54.
28. Burgess JK, Blake AE, Boustany S et al. CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol 2005; 115:302-8.
29. Nguyen NL, Chen K, McAleer J, Kolls JK. Vitamin D regulation of OX40 ligand in immune responses to Aspergillus fumigatus. Infect Immun 2013; 81:1510-9.
30. Reese TA, Liang HE, Tager AM et al. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007; 447:92-6.
31. Roy RM, Wuthrich M, Klein BS. Chitin elicits CCL2 from airway epithelial cells and induces CCR2-dependent innate allergic inflammation in the lung. J Immunol 2012; 189:2545-52.
32. Ferreira DS, Annoni R, Silva LF et al. Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma. Clin Exp Allergy 2012; 42:1459-71.
33. Duez C, Gosset P, Tonnel AB. Dendritic cells and toll-like receptors in allergy and asthma. Eur J Dermatol 2006; 16:12-6.
34. Braun-Fahrlander C, Riedler J, Herz U et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869-77.
35. Mintz-Cole RA, Gibson AM, Bass SA, Budelsky AL, Reponen T, Hershey GK. Dectin-1 and IL-17A suppress murine asthma induced by Aspergillus versicolor but not Cladosporium cladosporioides due to differences in beta-glucan surface exposure. J Immunol 2012; 189:3609-17.
36. Law SK. C3 receptors on macrophages. J Cell Sci Suppl 1988; 9:67-97.
37. Ghosh S, Hoselton SA, Schuh JM. mu-chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model. J Immunol 2012; 189:1322-9.
38. Dakhama A, Collins ML, Ohnishi H et al. IL-13-producing BLT1-positive CD8 cells are increased in asthma and are associated with airway obstruction. Allergy 2013; 68:666-73.
39. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110:685-92.
40. Chauhan B, Knutsen A, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 1996; 97:2324-31.
41. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135:805-26.
42. Moss RB. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis. Ann N Y Acad Sci 2012; 1272:49-57.
43. Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011; 2011:843763.
44. Slavin RG, Bedrossian CW, Hutcheson PS et al. A pathologic study of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1988; 81:718-25.
45. Hemmann S, Nikolaizik WH, Schoni MH, Blaser K, Crameri R. Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol 1998; 28:1155-60.
46. Nikolaizik WH, Weichel M, Blaser K, Crameri R. Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy. Am J Respir Crit Care Med 2002; 165:916-21.
47. Umetsu DT, Akbari O, Dekruyff RH. Regulatory T cells control the development of allergic disease and asthma. J Allergy Clin Immunol 2003; 112:480-7; quiz 488.
48. Bacher P, Kniemeyer O, Schonbrunn A et al. Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi. Mucosal Immunol 2014; 7:916-28 [As per pubMed].
49. Fei M, Bhatia S, Oriss TB et al. TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc Natl Acad Sci USA 2011; 108:5360-5.
50. Nagarkar DR, Poposki JA, Comeau MR et al. Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin. J Allergy Clin Immunol 2012; 130:225-32.
51. Krause K, Metz M, Makris M, Zuberbier T, Maurer M. The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol 2012; 12:477-84.
52. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203:269-73.
53. Gauvreau GM, Boulet LP, Cockcroft DW et al. OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy 2014; 44:29-37.
54. Sugamura K, Ishii N, Weinberg AD. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 2004; 4:420-31.
55. Soumelis V, Reche PA, Kanzler H et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunol 2002; 3:673-80.
56. Blease K, Jakubzick C, Westwick J, Lukacs N, Kunkel SL, Hogaboam CM. Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 2001; 166:5219-24.
57. Fajt ML, Wenzel SE. Biologic therapy in asthma: entering the new age of personalized medicine. J Asthma 2014; 1-8 [Epub ahead of print].
58. Wong R, Wong M, Robinson PD, Fitzgerald DA. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis. Paediatr Respir Rev 2013; 14:22-4.
59. Collins J, Devos G, Hudes G, Rosenstreich D. Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab. J Asthma Allergy 2012; 5:65-70.
60. Homma T, Kurokawa M, Matsukura S, Yamaguchi M, Adachi M. Anti-IgE therapy for allergic bronchopulmonary aspergillosis. J Microbiol Immunol Infect 2013; [Epub 2013 Dec 03].
61. Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol 2010; 38:3-10.
62. Safdar A. Immunotherapy for invasive mold disease in severely immunosuppressed patients. Clin Infect Dis 2013; 57:94-100.
63. Vaid M, Kaur S, Sambatakou H, Madan T, Denning DW, Sarma PU. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 2007; 45:183-6.
64. Saxena S, Madan T, Shah A, Muralidhar K, Sarma PU. Association of polymorphisms in the collagen region of SP-A2 with increased levels of total IgE antibodies and eosinophilia in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2003; 111:1001-7.
65. Knutsen AP, Kariuki B, Consolino JD, Warrier MR. IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary sspergillosis. Clin Mol Allergy 2006; 4:3.
66. Brouard J, Knauer N, Boelle PY et al. Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis. J Infect Dis 2005; 191:1988-91.